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The idea that an excessive release of glutamate mediates neuronal cell death was proposed, as the excitotoxicity hypothesis, by Olney and de-Gubareff. 1) Glutamate activates two types of its receptor, N-methyl-D-aspartate (NMDA) type and non-NMDA one. 2) Excessive activation of glutamate receptors, resulting in increase in intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) and generation of reactive oxygen species (ROS), is involved in neuronal disorder and degeneration. 3) Both phenomena induced by glutamate are related to cell injury and death. 4, 5) In fact, antagonists for NMDA and non-NMDA glutamate receptors are proven to possess neuroprotective action. [6] [7] [8] Extract of Ginkgo biloba leaves (EGBL) is expected to treat patients with some neuronal disorders such as dementia and Alzheimer's disease. 9, 10) The extract exerts protective action (or antioxidant action) on neurons suffering from oxidative stress induced by hydrogen peroxide, one of ROS, and by overload of intracellular Ca 2ϩ . 7, 11, 12) EGBL and its constituents inhibit the response mediated by activation of NMDA receptor. 13, 14) However, there is limited information concerning the effect of EGBL on response induced by activation of non-NMDA glutamate receptor. Kainate, an agonist for non-NMDA glutamate receptor, increases [Ca 2ϩ ]i in neurons via activations of non-NMDA glutamate receptor and voltage-dependent Ca 2ϩ channel. 15) Therefore, in order to elucidate one of mechanisms for neuroprotective action of EGBL, we examined the effect of EGBL on kainate-induced increase in [Ca 2ϩ ]i in rat brain neurons using a laser microscope with fluorescent Ca 2ϩ -indicator.
MATERIALS AND METHODS

Materials
Extract of Ginkgo biloba leaves (EGBL) was obtained from Icho-Ha Sangyo Co., Ltd., Ibaraki, Japan. EGBL was initially dissolved in 50% ethanol. EGBL solution (1-30 mg/ml) was added to bathing solution to achieve appropriate concentrations (1-30 mg/ml). Ethanol as a solvent at 0.05% did not affect any fluorescence measurements from cells. Other chemical reagents except for fluorescent probes were purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.) unless otherwise mentioned.
Cell Preparation Experimental method for dissociation of rat cerebellar neurons was similar to those described in previous studies. 16, 17) In brief, the slices of cerebellum dissected from 10-to 16-d-old Wistar strain rats were treated with 1000 protease units/ml dispase (Godo Shusei, Tokyo, Japan) in Tyrode's solution for 50-60 min at a temperature of 32-34°C. After enzymatic treatment, cerebellar neurons were dispersed by triturating in Tyrode's solution. Since the majority of neurons were characterized by small size and spherical shape under microscopic observation, they were ascertained as cerebellar granule cells. These cells responded to kainate, resulting in an increase in [Ca 2ϩ ]i. 15) The cells were placed on culture dishes and incubated at 35-36°C in Tyrode's solution for 50-60 min before use. The application of chemicals to neurons was performed by a Y-tube technique.
18)
Measurements To estimate the change in intracellular Ca 2ϩ concentration of neurons with intact membranes, two fluorescent probes, fluo-3-AM (Dojindo Chemical Laboratory, Kumamoto, Japan) and propidium iodide (Molecular Probes Inc., Eugene, MO, U.S.A.), were used. 16, 17) Fluo-3 fluorescence is used for monitoring the change in [Ca 2ϩ ]i. 19) Propidium iodide, which is highly impermeant to intact membrane, cannot stain intact live cells. Excitation wavelength for fluo-3 and propidium was 488 nm produced by argon laser. Emissions were detected at wavelengths of 530Ϯ15 nm for fluo-3 fluorescence and 605 nm or longer for propidium fluorescence. Fluo-3 fluorescence was monitored from intact neurons that were not stained with propidium by a confocal laser microscope (Meridian Instruments Far East, Tokyo, Japan) and analyzed by a computer (Evolution V-Q 
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RESULTS
Effect of EGBL on Kainate-Induced Response of Rat Cerebellar Neurons Kainate at 30 mM increased the intensity of fluo-3 fluorescence in some neurons (Fig. 1) , but not all, and the number of cells responding to kainate was greater than those responding to glutamate or NMDA. 15) CNQX, an antagonist for non-NMDA glutamate receptor, at 10 mM almost completely suppressed the kainate-induced augmentation of fluo-3 fluorescence. 15) Control intensity of fluo-3 fluorescence monitored from neurons before the application of kainate was 359Ϯ204 (control value, arbitrary unit, meanϮS.D. of 25 experiments). The application of 30 mM kainate increased the intensity of fluo-3 fluorescence to 1045Ϯ222 (nϭ5) under control condition. EGBL (1-30 mg/ml) did not significantly affect the intensity of fluo-3 fluorescence.
As shown in Fig. 1 , 30 mg/ml EGBL greatly suppressed the kainate response at 15 min after the start of EGBL treatment. In the presence of EGBL, the kainate-induced increases in the intensity were 1074Ϯ232 (nϭ5) for in the case of 1 mg/ml EGBL, 814Ϯ345 (nϭ5) for 3 mg/ml EGBL, 486Ϯ160 (nϭ5) for 10 mg/ml, and 484Ϯ232 (nϭ4) for 30 mg/ml, respectively. Thus, EGBL at 3 mg/ml or more concentration-dependently attenuated the kainate-induced augmentation of fluo-3 fluorescence, suggesting that EGBL possesses an inhibitory action on the kainate response. Results are normalized and summarized in Fig. 2 .
Possible Site of Action of EGBL In the response to kainate in rat cerebellar neurons, there are two steps to increase [Ca 2ϩ ]i, activation of kainate receptor leading to membrane depolarization and then activation of voltage-dependent Ca 2ϩ channel by the depolarization. 15) Nicardipine at 30 mM completely suppressed the augmentation of fluo-3 fluorescence by 100 mM KCl and decreased the number of cells responding to kainate with increasing the intensity of fluo-3 fluorescence.
15) Therefore, it is important to see whether EGBL suppresses kainate receptor, voltage-dependent Ca 2ϩ channel, or both.
Control intensity of fluo-3 fluorescence was 405Ϯ188 (nϭ20). Under control condition, 30 mM kainate increased the intensity of fluo-3 fluorescence to 1728Ϯ342 (nϭ5) while it was 2125Ϯ248 (nϭ5) in the case of 50 mM KCl. However, in presence of 30 mg/ml EGBL, respective increases were 732Ϯ352 (nϭ5) for 30 mM kainate and 1929Ϯ449 (nϭ4) for 50 mM KCl. Thus, EGBL greatly suppressed the kainate response, but not the response induced by 50 mM KCl. Results are normalized and summarized in Fig.  3 .
As described above, it is suggested that EGBL suppresses kainate receptor rather than voltage-dependent Ca 2ϩ channel (Fig. 3) . To seek the site for inhibitory action of EGBL on kainate receptor, the effect of increasing kainate concentra- The concentrations of EGBL and kainate were 30 mg/ml and 30 mM, respectively. The traces were obtained before (CONTROL) and 15 min after the start of EGBL application (EGBL 30 mg/ml). tion on the EGBL-induced inhibition was examined.
Control intensity of fluo-3 fluorescence was 639Ϯ375 (nϭ29). Kainate at 30 mM and 100 mM increased the intensity of fluo-3 fluorescence to 1785Ϯ301 (nϭ7) and 2372Ϯ127 (nϭ8), respectively. However, in presence of 30 mg/ml EGBL (15 min preincubation), the increases were 891Ϯ370 (nϭ6) for 30 mM kainate and 2001Ϯ187 (nϭ7) for 100 mM kainate. Thus, it is suggested that EGBL competes for receptor site with kainate. Results are normalized and summarized in Fig.  4 . It is noted that the preincubation of neurons with EGBL is required to exert the inhibitory action on kainate receptor.
DISCUSSION
EGBL is used to treat or prevent some neurodegenerative diseases as well as stroke although the weight of evidence regarding its effect is not sufficient to define clinical practice. We have shown that EGBL protects neurons suffering from oxidative stress induced by hydrogen peroxide 7) and decreases oxidative metabolism in resting and Ca 2ϩ -loaded neurons. 12, 16) Oxidative stress is also induced by abnormally increasing [Ca 2ϩ ]i in neurons. 20, 21) Therefore, if EGBL prevents increasing [Ca 2ϩ ]i of neurons by excessive activation of glutamate receptor, it would contribute to the neuroprotective action of EGBL. In this study, EGBL at concentrations of 3 mg/ml or more decreased the increase in [Ca 2ϩ ]i induced by kainate via an activation of non-NMDA receptor (Fig. 2) . At concentrations of 10-30 mg/ml, EGBL completely suppressed the increase in [Ca 2ϩ ]i induced by kainate in some neurons (Fig. 2) . Thus, EGBL may exert neuroprotective action via suppression of increase in [Ca 2ϩ ]i by activation of non-NMDA glutamate receptor.
Kainate-induced increase in [Ca 2ϩ ]i of neurons is mediated via activations of both non-NMDA receptor and voltage-dependent Ca 2ϩ channel (Fig. 3) . 15 ]i induced by 50 mM KCl (membrane depolarization) (Fig. 3) . Therefore, it can be suggested that EGBL blocks non-NMDA receptor-channel rather than voltage-dependent Ca 2ϩ channel.
EGBL consisting of flavone glycosides and terpene lactones is known to be an antioxidant. 7) Some constituents of EGBL are reported to suppress the response mediated by NMDA glutamate receptor. 13, 14) Furthermore, in present study, EGBL is shown to exert an inhibitory action on non-NMDA glutamate receptor. Some neurodegenerative diseases are resulted from cell death induced by glutamate excitotoxicity and oxidative stress. [3] [4] [5] Therefore, EGBL may be very suitable for preventing and/or treating such diseases. The intensity of fluo-3 fluorescence augmented by kainate was relative to control value before the kainate application. Column and bar indicate mean and standard deviation of 6-8 experiments. Asterisks ( * ) show significant difference (pϽ0.05) between the groups with and without EGBL application.
